Butera Salvatore Thomas 4
4 · VOLITIONRX LTD · Filed May 4, 2021
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
Butera Salvatore Thomas
Director
Transactions
- Award
Common Stock
2021-05-01+150,000→ 150,000 total - Disposition to Issuer
Common Stock
2021-03-25−15,000→ 0 total
Holdings
- 7,000
Common Stock
Footnotes (3)
- [F1]The reported transaction involved a cancellation of unvested restricted stock units upon Dr. Butera's resignation as a director of the issuer.
- [F2]In connection with his employment as Chief Executive Officer of Volition Veterinary Diagnostics Development, LLC, Dr. Butera received restricted stock units subject to a 3-year vesting schedule, vesting as to 50,000 units on each of 05/01/22, 05/01/23 and 05/01/24, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
- [F3]These shares of Common Stock are jointly owned by Dr. Butera and his spouse.